SM Bhanushali, KM Modh, IS Anand, CN Patel, JB Dave.
SM Bhanushali*, KM Modh, IS Anand, CN Patel and JB Dave
Shri Sarvajanik Pharmacy College, Nr. Arvind Baug, Mehsana - 384 001, Gujarat, INDIA.
Volume - 2,
Issue - 2,
Year - 2010
Diabetes mellitus is a major and growing public health problem of the developed country. Diabetes mellitus is also associated with disease like hypertension, chronic heart disease, blindness etc.. Now days drug that are available in the market are just to control the diabetes. There are several novel approaches which might cure the diabetes. Defective glucose-stimulated insulin secretion by pancreatic islet ß cells could be cured with recombinant glucagon-like peptide 1 (GLP-1) or agonists of the GLP-1 receptor. Alternatively, decrease in GLP-1 clearance can be achieved with inhibition of Dipeptidylpeptidase IV (DP-IV) to reduce insulin resistance, enhanced insulin action. The role of peroxisome proliferator activated receptors (PPAR ?) in the regulation of lipid metabolism, insulin and triglycerides leads to the rationale design of several PPAR agonists. Gene therapy also generates greater hope for possible cure of diabetes. Sodium-Glucose Co-Transporter Inhibitor is also one of the novel target for lowering plasma glucose and improving insulin resistance by increasing renal glucose excretion. Under diabetic conditions, induced oxidative stress also activates the JNK pathway, which is involved in deterioration of pancreatic ß-cell function found in diabetes. Treatment with antioxidants and/or suppression of the JNK pathway protect ß-cells from some of the toxic effects of hyperglycemia could be the one of novel target therapy of diabetes mellitus.
Cite this article:
SM Bhanushali, KM Modh, IS Anand, CN Patel , JB Dave. Novel Approaches for Diabetes Mellitus: A Review. Research J. Pharmacology and Pharmacodynamics. 2010; 2(2):141-147.